{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T13:52:30Z","timestamp":1776779550787,"version":"3.51.2"},"reference-count":22,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Surg."],"abstract":"<jats:sec><jats:title>Objective<\/jats:title><jats:p>This study seeks to investigate the impact of histopathological evidence of histological prostatic inflammation (PI) on the surgical outcomes of patients with benign prostatic hyperplasia (BPH) undergoing transurethral bipolar enucleation of the prostate (BiLEP) after biopsy.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>We conducted a prospective study in which data were collected from 112 patients with BPH who underwent BiLEP immediately after prostate biopsy at the Department of Urology in our hospital between October 2020 and October 2023. This cohort included 52 patients with histopathological prostatic inflammation (BPH\u2009+\u2009PI group) and 60 patients with simple BPH (BPH group). Baseline characteristics, surgical details, International Prostate Symptom Score (IPSS), quality of life (QoL), post-void residual volume (PVR), maximum flow rate (Qmax), International Index of Erectile Function-5 (IIEF-5), postoperative pathology results, and surgical complications were compared between the two groups.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>The study findings indicate that in patients with BPH who underwent BiLEP, various parameters in the BPH\u2009+\u2009PI group including operation time, intraoperative flushing volume, hemoglobin drop value, postoperative white blood cells, postoperative C-reactive protein, and average pain score at 3 days postoperatively were significantly higher compared to those in the BPH group (<jats:italic>p<\/jats:italic>\u2009&amp;lt;\u20090.01). In addition, the IPSS and IIEF-5 scores of the BPH\u2009+\u2009PI group were significantly worse before surgery and at 2 weeks postoperatively compared to the BPH group (<jats:italic>p<\/jats:italic>\u2009&amp;lt;\u20090.01); however, no significant differences were observed between the two groups at 1 and 3 months postoperatively (<jats:italic>p<\/jats:italic>\u2009&amp;gt;\u20090.05). At 2 weeks postoperatively, the BPH\u2009+\u2009PI group exhibited significantly worse outcomes in terms of QoL, PVR, and Qmax compared to the BPH group (<jats:italic>p<\/jats:italic>\u2009&amp;lt;\u20090.01). However, there were no statistically significant differences between the two groups at 1 and 3 months postoperatively (<jats:italic>p<\/jats:italic>\u2009&amp;gt;\u20090.05). The incidence rates of postoperative complications, such as fever, prostatic capsule perforation, urinary tract irritation, bladder spasm, acute epididymitis, urinary tract infection, and urethral stricture, were higher in the BPH\u2009+\u2009PI group compared to the BPH group (<jats:italic>p<\/jats:italic>\u2009&amp;lt;\u20090.05). Nevertheless, there was no significant difference in the overall complication rates between the two groups (<jats:italic>p<\/jats:italic>\u2009&amp;gt;\u20090.05). There were no statistically significant differences observed between the two groups in postoperative irrigation volume, extubation time, hospitalization time, proportion of secondary operations, proportion of bladder injury, and proportion of urinary incontinence (<jats:italic>p<\/jats:italic>\u2009&amp;gt;\u20090.05). However, the proportion of reported prostate cancer after surgery in the BPH\u2009+\u2009PI group was significantly higher than that in the BPH group (<jats:italic>p<\/jats:italic>\u2009&amp;lt;\u20090.05).<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>Histopathological prostatic inflammation does not have a significant impact on the long-term efficacy of BiLEP surgery immediately after biopsy. However, it does prolong surgery time, increase surgery-related complications, and influence short-term surgical outcomes and patient treatment experience. Therefore, it may be advisable to administer a course of anti-inflammatory treatment before performing BiLEP in such patients. Nevertheless, further high-quality studies are necessary to validate this approach.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fsurg.2024.1390656","type":"journal-article","created":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T05:00:35Z","timestamp":1719810035000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["It is not the best option to perform transurethral enucleation of the prostate immediately after biopsy in patients with histological inflammation"],"prefix":"10.3389","volume":"11","author":[{"given":"Tengfei","family":"Gu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jie","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ting","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yongtao","family":"Pan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing","family":"Sha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2024,7,1]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1111\/bju.15286","article-title":"The rising worldwide impact of benign prostatic hyperplasia","volume":"127","author":"Launer","year":"2021","journal-title":"BJU Int"},{"key":"B2","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1007\/s11934-023-01150-z","article-title":"Prostatitis: a review","volume":"24","author":"Yebes","year":"2023","journal-title":"Curr Urol Rep"},{"key":"B3","doi-asserted-by":"publisher","first-page":"1086","DOI":"10.1111\/iju.14644","article-title":"Effects of inflammatory prostatitis on the development and progression of benign prostatic hyperplasia: a literature review","volume":"28","author":"Tsunemori","year":"2021","journal-title":"Int J Urol"},{"key":"B4","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1080\/13685538.2022.2050360","article-title":"The association between histological prostatitis and benign prostatic hyperplasia: a single-center retrospective study","volume":"25","author":"Li","year":"2022","journal-title":"Aging Male"},{"key":"B5","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.4102\/phcfm.v14i1.3736","article-title":"Serum prostate specific antigen is a good indicator of prostatic volume in men with benign prostatic hyperplasia","volume":"14","author":"Abotsi","year":"2022","journal-title":"Afr J Prim Health Care Fam Med"},{"key":"B6","doi-asserted-by":"publisher","first-page":"1523","DOI":"10.4103\/njcp.njcp_67_22","article-title":"Correlation between prostate volume and PSA in Nigerian men with symptomatic histologically-diagnosed benign prostatic hyperplasia","volume":"25","author":"Aigbe","year":"2022","journal-title":"Niger J Clin Pract"},{"key":"B7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.7754\/Clin.Lab.2019.190428","article-title":"Analysis of PSA-related indexes, neutrophil-to-lymphocyte ratio in patients with concurrent benign prostatic hyperplasia and histologic prostatitis","volume":"66","author":"Wang","year":"2020","journal-title":"Clin Lab"},{"key":"B8","doi-asserted-by":"publisher","first-page":"1675","DOI":"10.1089\/end.2020.1189","article-title":"En-bloc holmium laser enucleation of the prostate with early apical release: are we ready for a new paradigm?","volume":"35","author":"Tuccio","year":"2021","journal-title":"J Endourol"},{"key":"B9","doi-asserted-by":"publisher","first-page":"1026657","DOI":"10.3389\/fsurg.2022.1026657","article-title":"Clinical analysis of transurethral holmium laser enucleation in the treatment of benign prostatic hyperplasia with prostatic histological inflammation: a prospective research study","volume":"9","author":"Zhou","year":"2022","journal-title":"Front Surg"},{"key":"B10","doi-asserted-by":"publisher","first-page":"2771","DOI":"10.1007\/s00345-020-03106-1","article-title":"Inflammation is a target of medical treatment for lower urinary tract symptoms associated with benign prostatic hyperplasia","volume":"38","author":"De Nunzio","year":"2020","journal-title":"World J Urol"},{"key":"B11","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.ucl.2020.09.010","article-title":"Recent advances and current role of transperineal prostate biopsy","volume":"48","author":"Bhanji","year":"2021","journal-title":"Urol Clin North Am"},{"key":"B12","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1007\/s11934-022-01091-z","article-title":"Surgical complications in the management of benign prostatic hyperplasia treatment","volume":"23","author":"Ottaiano","year":"2022","journal-title":"Curr Urol Rep"},{"key":"B13","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/j.urology.2019.06.024","article-title":"Factors influencing intraoperative blood loss in patients undergoing holmium laser enucleation of the prostate (HoLEP) for benign prostatic hyperplasia: a large multicenter analysis","volume":"132","author":"Romero-Otero","year":"2019","journal-title":"Urology"},{"key":"B14","doi-asserted-by":"publisher","first-page":"4069787","DOI":"10.1155\/2022\/4069787","article-title":"Risk factors of urinary pathogenic bacteria infection after benign prostatic hyperplasia surgery and curative effect analysis of Shuangdong capsule intervention","volume":"2022","author":"Xu","year":"2022","journal-title":"Emerg Med Int"},{"key":"B15","doi-asserted-by":"publisher","first-page":"20943","DOI":"10.1038\/s41598-023-47773-7","article-title":"Pathogen species are the risk factors for postoperative infection of patients with transurethral resection of the prostate: a retrospective study","volume":"13","author":"Lin","year":"2023","journal-title":"Sci Rep"},{"key":"B16","doi-asserted-by":"publisher","first-page":"505","DOI":"10.22037\/uj.v0i0.5462","article-title":"Association between inflammation and lower urinary tract symptoms of benign prostatic hyperplasia","volume":"17","author":"Zhang","year":"2020","journal-title":"Urol J"},{"key":"B17","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1080\/0092623X.2020.1871142","article-title":"Sexuality, sexual orientation and chronic prostatitis","volume":"47","author":"Stamatiou","year":"2021","journal-title":"J Sex Marital Ther"},{"key":"B18","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1038\/s41391-022-00559-w","article-title":"Low quality of life in men with chronic prostatitis-like symptoms","volume":"25","author":"Sugimoto","year":"2022","journal-title":"Prostate Cancer Prostatic Dis"},{"key":"B19","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1111\/luts.12473","article-title":"Does histological prostatic histological inflammation during transurethral resection of the prostate for bladder outlet obstruction affect post-operative urinary outcomes?","volume":"15","author":"Arora","year":"2023","journal-title":"Low Urin Tract Symptoms"},{"key":"B20","first-page":"35","article-title":"LUTS in BPH patients with histological prostatitis before and after transurethral resection of the prostate","volume":"19","author":"Huang","year":"2013","journal-title":"Zhonghua Nan Ke Xue"},{"key":"B21","doi-asserted-by":"publisher","first-page":"e19663","DOI":"10.7759\/cureus.19663","article-title":"Risk factors for early urethral stricture after mono-polar transurethral prostate resection: a single-center experience","volume":"13","author":"G\u00fcr","year":"2021","journal-title":"Cureus"},{"key":"B22","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1097\/j.pain.0000000000001122","article-title":"Inflammation in the pathophysiology of neuropathic pain","volume":"159","author":"Sommer","year":"2018","journal-title":"Pain"}],"container-title":["Frontiers in Surgery"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fsurg.2024.1390656\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T05:00:42Z","timestamp":1719810042000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fsurg.2024.1390656\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,1]]},"references-count":22,"alternative-id":["10.3389\/fsurg.2024.1390656"],"URL":"https:\/\/doi.org\/10.3389\/fsurg.2024.1390656","relation":{},"ISSN":["2296-875X"],"issn-type":[{"value":"2296-875X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,7,1]]},"article-number":"1390656"}}